Literature DB >> 9050814

Secondary metrics for the assessment of bioequivalence.

L Endrenyi, L Tothfalusi.   

Abstract

Mesh：

Substances：

Year:  1997        PMID： 9050814     DOI： 10.1021/js960368n

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN： 0022-3549            Impact factor:   3.534


× No keyword cloud information.
  5 in total

1.  Evaluation of truncated areas in the assessment of bioequivalence of immediate release formulations of drugs with long half-lives and of Cmax with different dissolution rates.

Authors:  P Sathe; J Venitz; L Lesko
Journal:  Pharm Res       Date:  1999-06       Impact factor: 4.200

2.  Novel direct curve comparison metrics for bioequivalence.

Authors:  J E Polli; A M McLean
Journal:  Pharm Res       Date:  2001-06       Impact factor: 4.200

3.  When is a metric not a metric? Remarks on direct curve comparison in bioequivalence studies.

Authors:  Wojciech Jawień
Journal:  J Pharmacokinet Pharmacodyn       Date:  2009-06-21       Impact factor: 2.745

Review 4.  Using partial area for evaluation of bioavailability and bioequivalence.

Authors:  Mei-Ling Chen; Barbara Davit; Robert Lionberger; Zakaria Wahba; Hae-Young Ahn; Lawrence X Yu
Journal:  Pharm Res       Date:  2011-04-13       Impact factor: 4.200

5.  The Two Main Goals of Bioequivalence Studies.

Authors:  Laszlo Endrenyi; Henning H Blume; Laszlo Tothfalusi
Journal:  AAPS J       Date:  2017-02-02       Impact factor: 4.009
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.